## What is Multi-cancer Early Detection?

This implementation guide provides guidance on implementing the Multi-cancer Early Detection Test Report FHIR R4 message. 

A Multi-cancer Early Detection Test is based on a blood sample that is analysed for cancer markers. If markers are detected, the test can predict the probable body site that is the cancer origin.





<h3 id="licence-heading">Licence</h3>

<div markdown="span" class="alert alert-warning" role="alert"><h4 id="Licence"><i class="fas fa-gavel"></i> Licensing and Publisher</h4>
<ul>
<li>
CopyrightÂ© 2023+ NHS England Licensed under the Apache License, Version 2.0 (the &quot;License&quot;); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an &quot;AS IS&quot; BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7&#174; FHIR&#174; standard Copyright &#169; 2011+ HL7 The HL7&#174; FHIR&#174; standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.
<li>
Developed and authored by NHS England Interoperability Team.
</ul>
</div>